文章摘要
康丹红 高健 王永春 杨晓冬 孙盼盼.辛伐他汀治疗老年高血脂患者疗效与安全性的最佳剂量研究[J].,2015,15(31):6125-6127
辛伐他汀治疗老年高血脂患者疗效与安全性的最佳剂量研究
Efficacy and Safety of Optimal Dose of Simvastatin for Elderly Patients withHyperlipemia
  
DOI:
中文关键词: 高血脂症  辛伐他汀  老年  疗效  不良反应
英文关键词: Hyperlipemia  Simvastatin  Elderly  Efficacy  Adverse reaction
基金项目:
作者单位
康丹红 高健 王永春 杨晓冬 孙盼盼 辽宁省丹东市第一医院药学部 
摘要点击次数: 501
全文下载次数: 0
中文摘要:
      目的:观察不同剂量辛伐他汀治疗老年高血脂患者疗效与安全性。方法:将纳入研究的80 例老年高血脂患者随机分为高剂 量组和低剂量组,各40 例。高剂量组给予辛伐他汀剂40 mg/ 日,低剂量组给予20 mg/日。治疗2个月后观察疗效、血脂水平变化 情况,并统计两组不良反应的发生情况。结果:高剂量组总有效率95%显著高于低剂量组的80%(P<0.05);治疗后,两组TG、TC、 LDL-C、HDL-C 水平均有改善,与本组治疗前比较均有显著性差异(P 均<0.05),且高剂量组上述指标改善明显优于低剂量组(P 均<0.05);治疗期间两组不良反应发生率无统计学意义(P>0.05)。结论:辛伐他汀高剂量(40 mg/日)治疗老年高血脂的疗效优于 低剂量(20 mg/ 日),且不增加不良反应发生的风险。
英文摘要:
      Objective:To observe the efficacy and safety of different doses of simvastatin in the treatment of elderly patients with hyperlipemia.Methods:A total of 80 elderly patients with hyperlipemia were randomly divided into high dose group (n=40) and low dose group (n=40). The high dose group was treated with 40 mg/d simvastatin, while the low dose group, 20 mg/d simvastatin. After 2 months of treatment, the efficacy and blood lipid levels of the two groups were observed, and the incidence of adverse reactions in the two groups was analyzed.Results:The total effective rate(95%) in the high dose group was significantly higher than that(80%) in the low dose group (P<0.05). Compared with before treatment, the levels of TG, TC, LDL-C, HDL-C in the two groups after treatment were significantly improved( P<0.05), and the above indexes in the high dose group were significantly better than those in the low dose group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion:The efficacy of high dose of simvastatin(40mg/d) is better than that of low dose of simvastatin(20 mg/d) in the treatment of elderly patients with hyperlipemia, which does not increase the incidence of adverse reactions.
查看全文   查看/发表评论  下载PDF阅读器
关闭